CrowdStrike enters the final week of July down 9% on the week to $191.15, reversing most of the 12% gap-up from July 15 — and the tension sits squarely between analysts lifting targets through the weakness and short sellers who still show no sign of covering.
The short position has barely moved despite a bruising week. At 27.8 million shares, short interest is 11.1% of the free float — essentially unchanged from the 28.3 million level flagged in prior notes and roughly four times the June baseline of ~7.5 million shares. That persistence through a 9% decline tells its own story: shorts built this position deliberately and are not being forced out. The borrow market confirms why there is no urgency — availability is effectively uncapped, cost to borrow has ticked up modestly to 0.44% but remains well below the brief 0.98% spike seen on July 8, and the ORTEX short score of 32.4 sits comfortably in moderate territory. With the lending pool this loose and borrow costs this cheap, there is no mechanical pressure on the short side. Options positioning is similarly relaxed. The put/call ratio of 0.96 is well below its 20-day average of 1.34, meaning options buyers are leaning toward calls rather than hedging with puts — a notable contrast to the bearish signal that might be expected given the week's sell-off.
The Street narrative has turned unambiguously constructive even as the price slides. Morgan Stanley raised its target to $227 from $172 on July 21, one of the sharpest upward revisions in the cohort this week. Argus followed the next morning, lifting its target to $230. Combined with Citigroup's move to $250 on July 16 and BTIG's earlier push to $237, the analyst direction of travel is clear: targets are being reset higher across the board, and no firm has downgraded or trimmed in the recent window. The mean price target of $190.85 now sits essentially at the current price, which means the post-split target recalibration is still working through the system — Needham and Benchmark both carry prior targets that were adjusted from ~$780 down to the $230-235 range, reflecting the mechanics of the stock split rather than a fundamental view change. The bull case rests on AI-driven security expansion and a strong pipeline. The bear case is a familiar one for cybersecurity leaders: premium valuation in a crowded enterprise market. The PE at 135x and EV/EBITDA near 93x leave little margin for error at a price the Street barely considers undervalued.
CEO George Kurtz sold approximately $2.0 million worth of stock across multiple tranches on July 20, with individual trades ranging from around $24,000 to $509,000 at prices between $198 and $208. The 90-day net insider activity is a positive $7.5 million across 36,859 shares — net buying on that horizon — so Monday's sales look like routine plan-driven activity rather than a directional signal. State Street is worth noting on the institutional side: the firm added 37.8 million shares in the period ending June 30, a substantial position build that dwarfs the incremental flows from BlackRock and Geode over the same period.
History on earnings reactions provides limited comfort for those holding into August 25. The most recent quarterly print, on June 3, sent the stock down 6.5% on the day and 15.8% over the following five trading sessions. The prior event on June 17 — which appears to be a separate date-related entry in the data — produced a modest 0.8% gain. The cybersecurity sector is not helping: close peer RBRK is down 13.9% on the week, TENB has lost 20%, and even PANW is off 3%. The weakness is sector-wide rather than stock-specific, which limits the information content of CRWD's own decline but also removes any relative-strength cushion.
The setup into August 25 is the one to watch: shorts are well-anchored and unconstrained by borrow costs, analysts are constructive but targets barely clear the current price, and the last earnings print triggered a two-week, 16% drawdown. Whether renewed selling pressure pushes short interest toward a covering trigger — or whether the stock stabilises enough for the analyst upgrade cycle to reassert itself — is the question the August result will answer.
See the live data behind this article on ORTEX.
Open CRWD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
